RxDoctor Payments Data

Cynthia Jones

Family · Chatsworth, GANPI 1891087177

Payments from drug & device makers

$6,995in general payments, 2019–2025

Across 431 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$843
  • Lilly USA, LLC$783
  • Amgen$448
  • AstraZeneca$329
  • Takeda Pharmaceuticals U.S.A., Inc.$315
  • plus $3K from 32 others

What the payments were for

  • Food & beverage$6,969100%
  • Education$260%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,995 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$85,383
Medicare patients
270
Services billed
2,416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide300$438,444
MounjaroTirzepatide195$274,783
Trelegy ElliptaFluticasone/Umeclidin/Vilanter140$151,659
EliquisApixaban179$146,862
JardianceEmpagliflozin94$130,985
TrulicityDulaglutide58$82,448
Tresiba Flextouch U-200Insulin Degludec48$72,472
FarxigaDapagliflozin Propanediol76$70,775
JanuviaSitagliptin Phosphate69$53,788
LinzessLinaclotide51$50,965
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog49$46,877
VraylarCariprazine Hcl26$35,899
Tresiba Flextouch U-100Insulin Degludec37$28,596
XareltoRivaroxaban30$23,729
Breztri AerosphereBudesonide/Glycopyr/Formoterol32$23,488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$843$455,230316 claims
Lilly USA, LLCMounjaro, Trulicity$783$357,231253 claims
GSKTrelegy Ellipta, Breo Ellipta$191$162,020164 claims
PfizerEliquis$197$146,862179 claims
Boehringer IngelheimJardiance, Spiriva Respimat$117$136,447105 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$329$101,983128 claims
AbbVieLinzess, Vraylar, Synthroid$1,387$95,076236 claims
MerckJanuvia, Janumet$35$68,29583 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$315$18,86526 claims
Astellas Pharma US IncMyrbetriq$95$15,34613 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$300$15,26718 claims
Sumitomo Pharma America, Inc.Gemtesa$119$13,66723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.

Other family in Chatsworth

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →